31 Articles in January 2026
AKS Claims Allowed in D. Nev. Compounding Pharmacy Fraud Case
AKS Claims Proceed Against Compounding Pharmacy Accused of Kickbacks In a significant development for the pharmaceutical industry, a federal court in Nevada has ruled that claims under the Anti-Kickback Statute (AKS) can proceed against a compounding pharmacy accused of engaging in illegal kickback...
Health Law Alliance Appoints Dr. Martha Rumore as Of Counsel
Health Law Alliance Welcomes Compounding Expert Pharmacist-Attorney Dr. Martha Rumore as Of Counsel The Health Law Alliance has announced the appointment of Dr. Martha Rumore, a noted expert in pharmaceutical compounding and a licensed attorney, as Of Counsel.
Compounding Pharmacy Sues Lilly, Novo for GLP-1 Drug Monopoly
Lilly, Novo Sued Over GLP-1 Drug Dominance by Compounding Pharmacy In a significant legal development, pharmaceutical giants Eli Lilly and Novo Nordisk are facing a lawsuit from a compounding pharmacy that accuses them of monopolistic practices in the market for GLP-1 receptor agonists, a class of ...
Telehealth Exclusivity Wars Heat Up: GLP-1 Compounder Lawsuit
GLP-1 Compounder Lawsuit Highlights Telehealth Exclusivity Wars In a significant legal development affecting the peptide industry, a lawsuit involving a compounding pharmacy that produces GLP-1 (glucagon-like peptide-1) medications has brought to light the escalating competition over telehealth exc...
Criminal Prosecutions in the Peptide Industry: Recent Cases
The peptide industry, once a niche segment within the broader pharmaceutical landscape, has seen exponential growth over recent years.
Arizona Medical Board Guidelines for Peptide Therapy
As the therapeutic use of peptides expands across the United States, regulatory guidelines are evolving to keep pace with innovations in medical treatments.
Telemedicine Peptide Clinics Face New Compliance Requirements
In the evolving landscape of healthcare, telemedicine has emerged as a pivotal component, offering patients unprecedented access to medical services.
FDA Import Alerts Affecting Peptide Research Chemicals
The landscape of peptide research chemicals is evolving rapidly, driven by scientific advancements and increasing interest in their potential therapeutic applications.
California Peptide Regulations: Complete Legal Guide for 2025
As the global focus on personalized medicine and biotechnology sharpens, peptides have emerged as pivotal players in the pharmaceutical and research sectors.
Tirzepatide Compounding: Legal Gray Areas Explained
In recent years, the compounding of peptides like Tirzepatide has become a topic of significant debate and intrigue within the pharmaceutical and healthcare industries.
Major Peptide Supplier Faces Regulatory Action: Industry Impact
The peptide industry, a cornerstone of modern biomedical research and therapeutic development, is experiencing a seismic shift as one of its major suppliers faces significant regulatory action.
FDA Warning Letters to Peptide Suppliers: 2024-2025 Trends
In recent years, the peptide industry has witnessed significant growth, fueled by the potential therapeutic benefits of peptides in treating a wide array of conditions.
New York State Regulations on Peptide Prescribing
As the pharmaceutical and biotechnology industries continue to innovate, peptide-based treatments have emerged as a promising frontier in medicine.
International Peptide Regulations: How US Laws Compare
In the rapidly evolving world of biotechnology and pharmaceuticals, peptides are gaining unprecedented attention due to their potential in treating a range of conditions from metabolic disorders to cancer.
FDA Crackdown on Compounded Semaglutide: What You Need to Know
The increasing popularity of semaglutide, a medication initially developed to treat type 2 diabetes and later approved for weight management, has led to a surge in its use and a corresponding rise in the compounding of this peptide by pharmacies.
Peptide Market Shifts as Regulatory Pressure Increases
The peptide market, a cornerstone of modern pharmaceutical innovation, is experiencing a seismic shift as regulatory pressures intensify globally.
How FDA Defines "Drug" vs "Research Chemical" for Peptides
In an era where scientific advancements have propelled peptides to the forefront of medical research, the distinction between a "drug" and a "research chemical" becomes crucial for researchers, pharmaceutical companies, and regulatory bodies.
Research Peptide Disclaimers: Do They Provide Legal Protection?
In recent years, research peptides have gained significant attention within the scientific community, offering promising avenues for medical advancements and therapeutic interventions.
State-by-State Guide: Where Are Peptides Legal in 2025?
As the demand for peptides continues to grow in the realms of research and therapeutic applications, understanding the legal landscape surrounding these compounds is crucial for researchers, clinicians, and patients alike.
WADA and Sports Law: Peptides in Athletic Competition
The intersection of athletic competition and pharmacological enhancement has been a focal point of sports law and ethics for decades.
Texas Pharmacy Board Stance on Compounded Peptides
In recent years, the use of compounded peptides has surged in popularity due to their potential therapeutic benefits.
Florida Laws on Peptide Therapy Clinics and Telemedicine
As the landscape of healthcare evolves, peptide therapy has emerged as a promising frontier in personalized medicine. Particularly in Florida, a state known for its burgeoning healthcare sector, peptide therapy clinics are on the rise.
Recent DOJ Actions Against Illegal Peptide Distributors
The peptide industry, a burgeoning sector due to the potential therapeutic benefits of peptides in treating various diseases, finds itself under scrutiny as the U.S. Department of Justice (DOJ) intensifies its actions against illegal distributors.
Personal Importation of Peptides: FDA Guidelines and Risks
The world of pharmaceuticals is evolving, with peptides gaining significant attention in recent years due to their therapeutic potential.
Warning Letter Analysis: Common Violations by Peptide Companies
In the fast-evolving landscape of pharmaceuticals, peptides have emerged as a crucial segment due to their potential in treating a wide range of conditions.
The Legal Status of BPC-157: Not FDA Approved But Not Illegal?
In the rapidly evolving landscape of peptide research and application, BPC-157 stands out as a compound of significant interest. Despite its growing popularity, its legal status remains a topic of debate and confusion.
Customs Seizures of Imported Peptides: Legal Implications
The importation of peptides into the United States has seen a marked increase, driven by the burgeoning interest in their potential therapeutic applications. However, this trend has also led to a rise in customs seizures of these substances.
Compounding Pharmacy Industry Responds to GLP-1 Regulations
The compounding pharmacy industry is currently navigating a complex regulatory landscape, especially in light of recent changes to the guidelines surrounding the compounding of GLP-1 (glucagon-like peptide-1) receptor agonists.
GLP-1 Drug Shortage and FDA Compounding Guidelines Explained
In recent years, the pharmaceutical landscape has been significantly impacted by the emergence of GLP-1 receptor agonists, a class of drugs primarily used to treat type 2 diabetes and obesity.
Insurance Coverage for Peptide Therapy: Legal and Policy Updates
In recent years, peptide therapy has emerged as a promising treatment option in various medical fields, including endocrinology, dermatology, and neurology.
FDA Enforcement Actions Against Peptide Sellers: Case Studies
In recent years, the peptide industry has witnessed significant growth, driven by advancements in biotechnology and increased interest in personalized medicine.